Identifying Unique Scent Signature of Lung Cancer Through Body Odor
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of this study is to show that dogs are able to detect cancer in sweat samples. This potentially would be the base for developing a new efficient, non invasive and inexpensive diagnosis tool of lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2012
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
February 7, 2012
CompletedJune 4, 2013
June 1, 2013
January 27, 2012
June 2, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with lung neoplasms
Dogs ability to distinguish between COPD and lung cancer patients sweat samples
one year
Study Arms (2)
Lung Cancer Patients
diagnosed lung cancer patients .
COPD Patients
COPD patients, not diagnosed with lung cancer.
Eligibility Criteria
The recruitment process will take place at the lung department of Sheba medical center. The participating physicians will enroll the patients and sing them on the consent form when they come for their regular appointments.
You may qualify if:
- A diagnosis of lung cancer, regardless of histology.
You may not qualify if:
- Inability to comply with study and/or follow up procedure.
- Co morbidity of lung cancer and an additional malignancy combined.
- Patients taking part in another clinical trial and receiving any treatment for it.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheba Medical Center
Tel Hasomer, 52621, Israel
Biospecimen
sweat samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nir Peled, MD PhD FCCP
Sheba Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head, Thoracic Cancer Research and Detection Center,Tel Hashomer, Israel
Study Record Dates
First Submitted
January 27, 2012
First Posted
February 7, 2012
Study Start
February 1, 2012
Last Updated
June 4, 2013
Record last verified: 2013-06